Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 1720019)

Published in Arch Dis Child on August 01, 2004

Authors

B M de Oliveira1, M B Viana, C L Zani, A J Romanha

Author Affiliations

1: Haematology Division, Department of Paediatrics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. benigna@uol.com.br

Articles citing this

The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. J Acquir Immune Defic Syndr (2013) 1.63

Components of cure: treatment of acute lymphoblastic leukemia in Indonesia and other low-income countries. Pediatr Blood Cancer (2008) 0.90

The development of an objective methodology to measure medication adherence to oral thiopurines in paediatric patients with acute lymphoblastic leukaemia--an exploratory study. Eur J Clin Pharmacol (2009) 0.89

Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase. J Adolesc Young Adult Oncol (2015) 0.89

Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics. Br J Haematol (2014) 0.86

Compliance with a protocol for acute lymphoblastic leukemia in childhood. Rev Bras Hematol Hemoter (2011) 0.86

Socioeconomic variation in survival from childhood leukaemia in northern England, 1968-2010. Br J Cancer (2013) 0.81

Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003. Br J Haematol (2015) 0.81

Medical and psychosocial associates of nonadherence in adolescents with cancer. J Pediatr Oncol Nurs (2014) 0.78

Adherence to antibiotic prophylaxis in children with vesicoureteral reflux. Adv Urol (2011) 0.75

Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia. PLoS One (2017) 0.75

Articles cited by this

Development of normalized curves for the international growth reference: historical and technical considerations. Am J Clin Nutr (1987) 7.19

Non-compliance--or how many aunts has Matilda? Lancet (1993) 5.58

Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet (1996) 5.41

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst (1999) 3.58

A new method for estimating a standardized prevalence of child malnutrition from anthropometric indicators. Bull World Health Organ (1989) 2.37

Non-compliance with oral chemotherapy in childhood leukaemia. BMJ (1996) 2.02

A reliable method for evaluating drug compliance in children with cancer. Cancer (1979) 2.00

Compliance of pediatric and adolescent cancer patients. Cancer (1986) 1.97

Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador. J Pediatr Hematol Oncol (2000) 1.83

High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. J Chromatogr (1992) 1.50

Compliance in adolescents with chronic diseases: a review. J Adolesc Health (2000) 1.38

Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance? BMJ (1993) 1.28

Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance? Br J Cancer (1995) 1.25

Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. J Pediatr (1992) 1.23

Drug compliance in pediatrics. Clinical and research issues. Pediatr Clin North Am (1997) 1.20

Patient compliance: recognition of factors involved and suggestions for promoting compliance with therapeutic regimens. J Adv Nurs (1996) 1.14

The TREAT (Therapeutic Regimens Enhancing Adherence in Teens) program: theory and preliminary results. J Adolesc Health (2001) 1.09

Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC. Clin Chem (1998) 1.06

Compliance with chemotherapy in childhood leukaemia in Africa. S Afr Med J (1989) 1.04

Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol (1998) 1.03

Pattern of 6-mercaptopurine urinary excretion in children with acute lymphoblastic leukemia: urinary assays as a measure of drug compliance. Ther Drug Monit (1992) 0.99

Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells. J Chromatogr (1987) 0.98

Compliance with oral chemotherapy in childhood lymphoblastic leukaemia. Cancer Treat Rev (1995) 0.97

Refusal, non-compliance, and abandonment of treatment in children and adolescents with cancer: a report of the SIOP Working Committee on Phychosocial Issues in Pediatric Oncology. Med Pediatr Oncol (2002) 0.97

Factors affecting survival in White and Asian children with acute lymphoblastic leukaemia. Br J Cancer (2000) 0.92

Profile of non-compliance in lymphoblastic leukaemia. Arch Dis Child (1997) 0.86

International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November-1 December 2000. Leukemia (2001) 0.85

Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia. Haematologica (2001) 0.85

Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukaemia: implications for treatment outcome. Leuk Res (1985) 0.83

Psychological correlates of compliance. Am J Pediatr Hematol Oncol (1983) 0.83

Rapid method for evaluating compliance of 6-mercaptopurine therapy in children with leukemia. J Chromatogr (1988) 0.78

Direct association of socio-economic status with T-cell acute lymphoblastic leukaemia in children. Leuk Res (2003) 0.78

Articles by these authors

A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz (2009) 4.27

Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob Agents Chemother (2000) 1.87

Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles. Proc Natl Acad Sci U S A (1980) 1.78

Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect (2000) 1.63

Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Mol Biochem Parasitol (1998) 1.53

Simple form of clinical sample preservation and Leishmania DNA extraction from human lesions for diagnosis of American cutaneous leishmaniasis via polymerase chain reaction. Am J Trop Med Hyg (2001) 1.53

American cutaneous leishmaniasis: use of a skin test as a predictor of relapse after treatment. Bull World Health Organ (2000) 1.51

Biological screening of Brazilian medicinal plants. Mem Inst Oswaldo Cruz (2000) 1.30

Screening of Asteraceae (Compositae) plant extracts for larvicidal activity against Aedes fluviatilis (Diptera:Culicidae). Mem Inst Oswaldo Cruz (1998) 1.30

Characterization of Trypanosoma rangeli strains isolated in Central and South America: an overview. Mem Inst Oswaldo Cruz (1999) 1.26

In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi. J Antimicrob Chemother (2000) 1.23

Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia. Leukemia (2009) 1.23

The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I. Curr Med Chem (2012) 1.20

Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi. Antimicrob Agents Chemother (1998) 1.15

Risk factors for alloimmunization by patients with sickle cell disease. Braz J Med Biol Res (2005) 1.15

Genetic filtering and optimal sampling of Schistosoma mansoni populations. Parasitology (2006) 1.15

A study of experimental reinfection by Trypanosoma cruzi in dogs. Am J Trop Med Hyg (2001) 1.12

The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II. Curr Med Chem (2012) 1.09

Leishmania identification by PCR of Giemsa-stained lesion imprint slides stored for up to 36 years. Clin Microbiol Infect (2006) 1.07

Genetic variability in Brazilian triatomines and the risk of domiciliation. Mem Inst Oswaldo Cruz (1999) 1.07

Antiplasmodial triterpene from Vernonia brasiliana. Planta Med (1997) 1.05

Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease. Clin Diagn Lab Immunol (2001) 1.02

Populational structure of Schistosoma mansoni assessed by DNA microsatellites. Int J Parasitol (2002) 1.02

Dual role of 5-HT in defense and anxiety. Neurosci Biobehav Rev (1997) 1.00

Characterization of new Schistosoma mansoni microsatellite loci in sequences obtained from public DNA databases and microsatellite enriched genomic libraries. Mem Inst Oswaldo Cruz (2002) 1.00

Random amplified polymorphic DNA analysis of Trypanosoma cruzi strains. Mol Biochem Parasitol (1993) 0.98

Further studies on erythrocyte thiamin transport and phosphorylation in seven patients with thiamin-responsive megaloblastic anaemia. J Inherit Metab Dis (1994) 0.97

Polygodial, the fungitoxic component from the Brazilian medicinal plant Polygonum punctatum. Mem Inst Oswaldo Cruz (2001) 0.97

IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-gamma. Eur J Immunol (2001) 0.96

Thiamine-responsive megaloblastic anemia, sensorineural deafness, and diabetes mellitus: A new syndrome? J Pediatr (1978) 0.94

Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes. Mem Inst Oswaldo Cruz (1993) 0.94

Genetic variability of Triatoma brasiliensis (Hemiptera: Reduviidae) populations. J Med Entomol (2000) 0.94

In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Parasitology (1998) 0.93

Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia. Arch Dis Child (1997) 0.92

Surface antigens of stocks and clones of Trypanosoma cruzi isolated from humans. Acta Trop (1984) 0.92

The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests. Braz J Med Biol Res (2005) 0.92

Isoenzyme profile as parameter to differentiate pathogenic strains of Entamoeba histolytica in Brazil. Rev Inst Med Trop Sao Paulo (1997) 0.92

Reliability of isoelectrofocusing for the detection of Hb S, Hb C, and HB D in a pioneering population-based program of newborn screening in Brazil. Hemoglobin (2001) 0.90

Trypanocidal activity of lipophilic diamines and amino alcohols. Biomed Pharmacother (2010) 0.90

Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK/STAT pathway. Infect Immun (1999) 0.89

Low-stringency PCR with diagnostically useful primers for identification of Leptospira serovars. J Clin Microbiol (1994) 0.89

Biological activities of 7-epiclusianone. J Nat Prod (1999) 0.89

Leishmania (Viannia) braziliensis is the predominant species infecting patients with American cutaneous leishmaniasis in the State of Minas Gerais, Southeast Brazil. Acta Trop (1999) 0.89

Mini-exon gene sequence polymorphism among Trypanosoma rangeli strains isolated from distinct geographical regions. Parasitology (1999) 0.88

Early, intermediate, and late acute stages in Chagas' disease: a study combining anti-galactose IgG, specific serodiagnosis, and polymerase chain reaction analysis. Am J Trop Med Hyg (1999) 0.88

[Isolation of Trypanosoma cruzi samples by xenodiagnosis and hemoculture from patients with chronic Chagas' disease]. Mem Inst Oswaldo Cruz (1990) 0.87

Identification of morphologically similar Rhodnius species (Hemiptera: Reduviidae: Triatominae) by electrophoresis of salivary heme proteins. Am J Trop Med Hyg (2000) 0.87

Subclassification of acute lymphoblastic leukaemia in children: analysis of the reproducibility of morphological criteria and prognostic implications. Br J Haematol (1980) 0.87

Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze. Eur J Pharmacol (1999) 0.87

A reliable and specific enzyme-linked immunosorbent assay for the capture of IgM from human chagasic sera using fixed epimastigotes of Trypanosoma cruzi. Parasitol Res (2000) 0.87

[Cutaneous leishmaniasis in the Metropolitan Region of Belo Horizonte: clinical, laboratorial, therapeutic and prognosis features (1989-1995)]. Rev Soc Bras Med Trop (2001) 0.87

In vitro activity of hypnophilin from Lentinus strigosus: a potential prototype for Chagas disease and leishmaniasis chemotherapy. Braz J Med Biol Res (2010) 0.86

Characterization of Leishmania sp. strains isolated from autochthonous cases of human cutaneous leishmaniasis in Santa Catarina State, southern Brazil. Acta Trop (2000) 0.86

Identification and characterization of bioemulsifier-producing yeasts isolated from effluents of a dairy industry. Bioresour Technol (2010) 0.86

Use of nondenaturing silver-stained polyacrylamide gel analysis of polymerase chain reaction amplification products for the differential diagnosis of Leptospira interrogans infection. Diagn Microbiol Infect Dis (1995) 0.85

Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia. Haematologica (2001) 0.85

Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze. Pharmacol Biochem Behav (1996) 0.85

Serotonergic regulation of inhibitory avoidance and one-way escape in the rat elevated T-maze. Neurosci Biobehav Rev (2001) 0.85

The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families. Hum Mutat (2000) 0.84

Chronic unpredictable mild stress alters an anxiety-related defensive response, Fos immunoreactivity and hippocampal adult neurogenesis. Behav Brain Res (2013) 0.84

In-vivo treatment with benznidazole enhances phagocytosis, parasite destruction and cytokine release by macrophages during infection with a drug-susceptible but not with a derived drug-resistant Trypansoma cruzi population. Parasite Immunol (1999) 0.84

Randomly amplified polymorphic DNA (RAPD) and isoenzyme analysis of Trypanosoma rangeli strains. J Eukaryot Microbiol (1994) 0.84

Changes in the isoenzyme and kinetoplast DNA patterns of Trypanosoma cruzi strains induced by maintenance in mice. Acta Trop (1990) 0.83

The threat of reintroduction of natural transmission of Chagas' disease in Bambuí, Minas Gerais State, Brazil, due to Panstrongylus megistus. Mem Inst Oswaldo Cruz (1993) 0.83

Antifungal activities of compounds isolated from Piper abutiloides Kunth. Mycoses (2009) 0.82

Low-stringency PCR provides an internal control for negative results in PCR-based diagnosis. PCR Methods Appl (1994) 0.82

Refined mapping of the gene for thiamine-responsive megaloblastic anemia syndrome and evidence for genetic homogeneity. Hum Genet (1998) 0.81

Effects of reversible inactivation of the dorsomedial hypothalamus on panic- and anxiety-related responses in rats. Braz J Med Biol Res (2010) 0.81

Drug resistance in Trypanosoma cruzi is not associated with amplification or overexpression of P-glycoprotein (PGP) genes. Mol Biochem Parasitol (2001) 0.81

Clinical and molecular characterization of hemoglobin Maputo [beta 47 (CD6) Asp > Tyr HBB: c.142G > T] and G-Ferrara [beta 57 (E1) Asn > Lys HBB: c.174C > A] in a newborn screening in Brazil. Int J Lab Hematol (2012) 0.81

Effects of anxiety and memory of systemic and intra-amygdala injection of 5-HT3 receptor antagonist BRL 46470A. Neuropsychobiology (1996) 0.81

Effect of acute treatment with a water-alcohol extract of Erythrina mulungu on anxiety-related responses in rats. Braz J Med Biol Res (2002) 0.81

Trypanosoma rangeli (Tejera, 1920) isolated from a sylvatic rodent (Echimys dasythrix) in Santa Catarina Island, Santa Catarina State: first report of this trypanosome in southern Brazil. Mem Inst Oswaldo Cruz (1993) 0.80

The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam. Braz J Med Biol Res (1993) 0.80

Trypanocidal flavonoids from Trixis vauthieri. J Nat Prod (1997) 0.80

Morning steroid profile in children with congenital adrenal hyperplasia under different hydrocortisone schedules. Indian J Pediatr (1995) 0.80

Effect of Erythrina velutina and Erythrina mulungu in rats submitted to animal models of anxiety and depression. Braz J Med Biol Res (2006) 0.80

A simplified method for sample collection and DNA isolation for polymerase chain reaction detection of Trypanosoma rangeli and Trypanosoma cruzi in triatomine vectors. Mem Inst Oswaldo Cruz (2000) 0.80

[Use of random amplified polymorphic DNA (RAPD) in the populational study of Triatoma brasiliensis Neiva, 1911]. Cad Saude Publica (2000) 0.80

5-HT(2A) receptor activation in the dorsolateral septum facilitates inhibitory avoidance in the elevated T-maze. Behav Brain Res (2011) 0.79

An improved HPLC method for the quantitation of 6-mercaptopurine and its metabolites in red blood cells. Braz J Med Biol Res (2004) 0.79

Effects of chronic treatment with corticosterone and imipramine on fos immunoreactivity and adult hippocampal neurogenesis. Behav Brain Res (2012) 0.79

Characterization of Trypanosoma cruzi. Mem Inst Oswaldo Cruz (1999) 0.79

Influence of the long-term Trypanosoma cruzi infection in vertebrate host on the genetic and biological diversity of the parasite. Parasitol Res (2005) 0.79

Trypanosomatid isolates from Honduras: differentiation between Trypanosoma cruzi and Trypanosoma rangeli. Am J Trop Med Hyg (1991) 0.79

A new cyclohexadecane derivative from Trixis vauthieri DC (Asteraceae). Org Lett (1999) 0.79

Trypanosomatidae diseases: from the current therapy to the efficacious role of trypanothione reductase in drug discovery. Curr Med Chem (2013) 0.79

[Relationships between Trypanosoma cruzi transmission cycles in the county of Bambuí, Minas Gerais, Brazil]. Cad Saude Publica (2003) 0.79

Characterization of Trypanosoma cruzi strains isolated from chronic chagasic patients, triatomines and opossums naturally infected from the State of Rio Grande do Sul, Brazil. Mem Inst Oswaldo Cruz (1998) 0.79

Characterization of two isolates of Trypanosoma cruzi obtained from the patient Berenice, the first human case of Chagas' disease described by Carlos Chagas in 1909. Parasitol Res (1996) 0.78

The use of RAPDs for the study of the genetic diversity of Schistosoma mansoni and Trypanosoma cruzi. EXS (1993) 0.78

Attempt to differentiate Leishmania (Leishmania) amazonensis, L. (L.) chagasi, Leishmania (Viannia) braziliensis and L. (V.) guyanensis using the SSR-PCR technique. Parasitol Res (2001) 0.78

Homozygous Hb Stanleyville-II [alpha2 78(EF7) Asn>Lys; HBA2:c.237C>A, not C>G] associated with genotype -α 3.7/-α 3.7 in two Brazilian families. Int J Lab Hematol (2011) 0.78

Concanavalin a receptors on the cell membrane of Trypanosoma cruzi. Acta Trop (1978) 0.78